Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation

Hua Guo, Mariana M. Cajaiba, Dariusz Borys, Maria C. Gutierrez, Herman Yee, Rosa M. Drut, Ricardo Drut, Frederic Askin, Miguel Reyes-Múgica, M. Alba Greco

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM) of the lung is a rare but well-described malformative lesion of pulmonary parenchyma characterized by the abnormal maturation of airways along with an increase in terminal respiratory structures, resulting in cysts of variable sizes. Five types have been classified based on morphological analysis. Although the etiology of the lesion is still unclear, recent data suggest that bronchial atresia is a predisposing/associated anomaly. A described association between type 1 CCAM/CPAM and bronchioloalveolar carcinoma suggests that type 1 CCAM/CPAM may predispose to malignant transformation by as yet unidentified tumorigenic mechanisms. Here we studied epidermal growth factor receptor (EGFR) and K-RAS oncogene, 2 biological markers closely associated with tumorigenesis and altered in many types of tumors, including lung carcinomas. For this purpose, we used immunohistochemistry and gene sequencing in paraffin-embedded tissue. Our results demonstrate expression of EGFR in types 1 and 3 CCAM/CPAM, with a distinctive distribution and intensity, compared with that of type 2. Of special interest, mucinous areas in 2 cases of type 1 CCAM/CPAM lacked EGFR expression, whereas adjacent epithelial cystic linings were strongly positive. This supports the hypothesis that mucinous differentiation in CCAM/CPAM, always present in cases with malignant transformation, could be related to other molecular pathways. The K-RAS gene was screened for mutations usually found in lung carcinomas; however, no mutations were present in any of the studied samples. These findings support the notion that EGFR may play an important role in the pathogenesis and phenotype of CCAM/CPAM.

Original languageEnglish (US)
Pages (from-to)1772-1778
Number of pages7
JournalHuman Pathology
Volume38
Issue number12
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Epidermal Growth Factor Receptor
Lung
Mutation
Bronchiolo-Alveolar Adenocarcinoma
Carcinoma
Oncogenes
Paraffin
Genes
Cysts
Carcinogenesis
Biomarkers
Immunohistochemistry
Phenotype

Keywords

  • Bronchioloalveolar carcinoma (BAC)
  • Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM)
  • Epidermal growth factor receptor (EGFR)
  • K-RAS

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation. / Guo, Hua; Cajaiba, Mariana M.; Borys, Dariusz; Gutierrez, Maria C.; Yee, Herman; Drut, Rosa M.; Drut, Ricardo; Askin, Frederic; Reyes-Múgica, Miguel; Greco, M. Alba.

In: Human Pathology, Vol. 38, No. 12, 12.2007, p. 1772-1778.

Research output: Contribution to journalArticle

Guo, H, Cajaiba, MM, Borys, D, Gutierrez, MC, Yee, H, Drut, RM, Drut, R, Askin, F, Reyes-Múgica, M & Greco, MA 2007, 'Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation', Human Pathology, vol. 38, no. 12, pp. 1772-1778. https://doi.org/10.1016/j.humpath.2007.04.009
Guo, Hua ; Cajaiba, Mariana M. ; Borys, Dariusz ; Gutierrez, Maria C. ; Yee, Herman ; Drut, Rosa M. ; Drut, Ricardo ; Askin, Frederic ; Reyes-Múgica, Miguel ; Greco, M. Alba. / Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation. In: Human Pathology. 2007 ; Vol. 38, No. 12. pp. 1772-1778.
@article{d3540b28d6884f8e8d4c0ac8f98fb906,
title = "Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation",
abstract = "Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM) of the lung is a rare but well-described malformative lesion of pulmonary parenchyma characterized by the abnormal maturation of airways along with an increase in terminal respiratory structures, resulting in cysts of variable sizes. Five types have been classified based on morphological analysis. Although the etiology of the lesion is still unclear, recent data suggest that bronchial atresia is a predisposing/associated anomaly. A described association between type 1 CCAM/CPAM and bronchioloalveolar carcinoma suggests that type 1 CCAM/CPAM may predispose to malignant transformation by as yet unidentified tumorigenic mechanisms. Here we studied epidermal growth factor receptor (EGFR) and K-RAS oncogene, 2 biological markers closely associated with tumorigenesis and altered in many types of tumors, including lung carcinomas. For this purpose, we used immunohistochemistry and gene sequencing in paraffin-embedded tissue. Our results demonstrate expression of EGFR in types 1 and 3 CCAM/CPAM, with a distinctive distribution and intensity, compared with that of type 2. Of special interest, mucinous areas in 2 cases of type 1 CCAM/CPAM lacked EGFR expression, whereas adjacent epithelial cystic linings were strongly positive. This supports the hypothesis that mucinous differentiation in CCAM/CPAM, always present in cases with malignant transformation, could be related to other molecular pathways. The K-RAS gene was screened for mutations usually found in lung carcinomas; however, no mutations were present in any of the studied samples. These findings support the notion that EGFR may play an important role in the pathogenesis and phenotype of CCAM/CPAM.",
keywords = "Bronchioloalveolar carcinoma (BAC), Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM), Epidermal growth factor receptor (EGFR), K-RAS",
author = "Hua Guo and Cajaiba, {Mariana M.} and Dariusz Borys and Gutierrez, {Maria C.} and Herman Yee and Drut, {Rosa M.} and Ricardo Drut and Frederic Askin and Miguel Reyes-M{\'u}gica and Greco, {M. Alba}",
year = "2007",
month = "12",
doi = "10.1016/j.humpath.2007.04.009",
language = "English (US)",
volume = "38",
pages = "1772--1778",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "12",

}

TY - JOUR

T1 - Expression of epidermal growth factor receptor, but not K-RAS mutations, is present in congenital cystic airway malformation/congenital pulmonary airway malformation

AU - Guo, Hua

AU - Cajaiba, Mariana M.

AU - Borys, Dariusz

AU - Gutierrez, Maria C.

AU - Yee, Herman

AU - Drut, Rosa M.

AU - Drut, Ricardo

AU - Askin, Frederic

AU - Reyes-Múgica, Miguel

AU - Greco, M. Alba

PY - 2007/12

Y1 - 2007/12

N2 - Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM) of the lung is a rare but well-described malformative lesion of pulmonary parenchyma characterized by the abnormal maturation of airways along with an increase in terminal respiratory structures, resulting in cysts of variable sizes. Five types have been classified based on morphological analysis. Although the etiology of the lesion is still unclear, recent data suggest that bronchial atresia is a predisposing/associated anomaly. A described association between type 1 CCAM/CPAM and bronchioloalveolar carcinoma suggests that type 1 CCAM/CPAM may predispose to malignant transformation by as yet unidentified tumorigenic mechanisms. Here we studied epidermal growth factor receptor (EGFR) and K-RAS oncogene, 2 biological markers closely associated with tumorigenesis and altered in many types of tumors, including lung carcinomas. For this purpose, we used immunohistochemistry and gene sequencing in paraffin-embedded tissue. Our results demonstrate expression of EGFR in types 1 and 3 CCAM/CPAM, with a distinctive distribution and intensity, compared with that of type 2. Of special interest, mucinous areas in 2 cases of type 1 CCAM/CPAM lacked EGFR expression, whereas adjacent epithelial cystic linings were strongly positive. This supports the hypothesis that mucinous differentiation in CCAM/CPAM, always present in cases with malignant transformation, could be related to other molecular pathways. The K-RAS gene was screened for mutations usually found in lung carcinomas; however, no mutations were present in any of the studied samples. These findings support the notion that EGFR may play an important role in the pathogenesis and phenotype of CCAM/CPAM.

AB - Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM) of the lung is a rare but well-described malformative lesion of pulmonary parenchyma characterized by the abnormal maturation of airways along with an increase in terminal respiratory structures, resulting in cysts of variable sizes. Five types have been classified based on morphological analysis. Although the etiology of the lesion is still unclear, recent data suggest that bronchial atresia is a predisposing/associated anomaly. A described association between type 1 CCAM/CPAM and bronchioloalveolar carcinoma suggests that type 1 CCAM/CPAM may predispose to malignant transformation by as yet unidentified tumorigenic mechanisms. Here we studied epidermal growth factor receptor (EGFR) and K-RAS oncogene, 2 biological markers closely associated with tumorigenesis and altered in many types of tumors, including lung carcinomas. For this purpose, we used immunohistochemistry and gene sequencing in paraffin-embedded tissue. Our results demonstrate expression of EGFR in types 1 and 3 CCAM/CPAM, with a distinctive distribution and intensity, compared with that of type 2. Of special interest, mucinous areas in 2 cases of type 1 CCAM/CPAM lacked EGFR expression, whereas adjacent epithelial cystic linings were strongly positive. This supports the hypothesis that mucinous differentiation in CCAM/CPAM, always present in cases with malignant transformation, could be related to other molecular pathways. The K-RAS gene was screened for mutations usually found in lung carcinomas; however, no mutations were present in any of the studied samples. These findings support the notion that EGFR may play an important role in the pathogenesis and phenotype of CCAM/CPAM.

KW - Bronchioloalveolar carcinoma (BAC)

KW - Congenital cystic airway malformation/congenital pulmonary airway malformation (CCAM/CPAM)

KW - Epidermal growth factor receptor (EGFR)

KW - K-RAS

UR - http://www.scopus.com/inward/record.url?scp=36549002197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36549002197&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2007.04.009

DO - 10.1016/j.humpath.2007.04.009

M3 - Article

C2 - 17714760

AN - SCOPUS:36549002197

VL - 38

SP - 1772

EP - 1778

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 12

ER -